TGTX US,+1
TG Therapeutics in, (TGTX US, +1) – Michael Weiss (CEO, 2011) purchased $350,000 worth of stock on June 26 at $7.04. Weiss is a “Smart Buyer” and has made two timely purchases in TGTX (Sept. 2012 at $2.25 and Dec. 2013 at $3.43) as well as a timely sale in the stock in December 2014 […]